SE9200199D0 - PHARMACEUTICAL COMPOSITION AND ITS USE - Google Patents

PHARMACEUTICAL COMPOSITION AND ITS USE

Info

Publication number
SE9200199D0
SE9200199D0 SE9200199A SE9200199A SE9200199D0 SE 9200199 D0 SE9200199 D0 SE 9200199D0 SE 9200199 A SE9200199 A SE 9200199A SE 9200199 A SE9200199 A SE 9200199A SE 9200199 D0 SE9200199 D0 SE 9200199D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
several
composition
affections
disaccharides
Prior art date
Application number
SE9200199A
Other languages
Swedish (sv)
Other versions
SE9200199L (en
Inventor
Rune Soeremark
Original Assignee
Rune Soeremark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rune Soeremark filed Critical Rune Soeremark
Priority to SE9200199A priority Critical patent/SE9200199L/en
Publication of SE9200199D0 publication Critical patent/SE9200199D0/en
Priority to AU34653/93A priority patent/AU3465393A/en
Priority to PCT/SE1993/000033 priority patent/WO1993014773A1/en
Publication of SE9200199L publication Critical patent/SE9200199L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof

Abstract

The present invention relates to a pharmaceutical composition, e.g. an ointment, a cream or a paste, which can be used to treat superficial skin and mucous membrane affections. The composition is a mixture, which comprises, in percent by weight: 5-60% ZnO; 10-70% of one or several of the substances, which belong to one or several of the groups disaccharides, monosaccharides and glycosides; and 3-30% vitamin E; the rest being mainly only pharmaceutically acceptable vehicles.
SE9200199A 1992-01-24 1992-01-24 PHARMACEUTICAL COMPOSITION AND ITS USE SE9200199L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9200199A SE9200199L (en) 1992-01-24 1992-01-24 PHARMACEUTICAL COMPOSITION AND ITS USE
AU34653/93A AU3465393A (en) 1992-01-24 1993-01-21 Pharmaceutic composition and its use
PCT/SE1993/000033 WO1993014773A1 (en) 1992-01-24 1993-01-21 Pharmaceutic composition and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9200199A SE9200199L (en) 1992-01-24 1992-01-24 PHARMACEUTICAL COMPOSITION AND ITS USE

Publications (2)

Publication Number Publication Date
SE9200199D0 true SE9200199D0 (en) 1992-01-24
SE9200199L SE9200199L (en) 1993-07-25

Family

ID=20385108

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9200199A SE9200199L (en) 1992-01-24 1992-01-24 PHARMACEUTICAL COMPOSITION AND ITS USE

Country Status (3)

Country Link
AU (1) AU3465393A (en)
SE (1) SE9200199L (en)
WO (1) WO1993014773A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710526A1 (en) * 1993-09-29 1995-04-07 Phil International Inc Cosmetic preparation containing zinc oxide and process for manufacturing it
FR2717079B1 (en) * 1994-03-11 1996-04-12 Oreal Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetic and / or dermatological field and methods using it.
DE19503423A1 (en) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhesive agents
AU1223199A (en) * 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
CO5150167A1 (en) * 1998-12-04 2002-04-29 Johnson & Johnson Consumer COMPOSITIONS FOR SKIN CARE, CONTAINING CINC SALTS AND RETINOIDS
US6964949B2 (en) 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US20030229048A1 (en) * 2002-04-30 2003-12-11 Dange Veerapaneni Methods and compositions for inhibition of irritation by disaccharide and metal ions
ES2233206B1 (en) * 2003-11-26 2007-03-01 TECNOLOGIA & VITAMINAS, S.L. CINC OXIDE BASED FORMULATION FOR THE PREVENTION AND TREATMENT OF DIARRHEA IN FARM ANIMALS.
FR2883750B1 (en) * 2005-04-04 2009-07-31 Virbac Sa Sa TOPICAL COMPOSITIONS AND USES THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002845A1 (en) * 1983-01-21 1984-08-02 Advanced Drug Tech Vitamin-containing skin care ointment

Also Published As

Publication number Publication date
AU3465393A (en) 1993-09-01
WO1993014773A1 (en) 1993-08-05
SE9200199L (en) 1993-07-25

Similar Documents

Publication Publication Date Title
CO4410203A1 (en) INSULIN ANALOG FORMULATIONS
ES2188656T3 (en) ANTIVIRAL COMPOSITION FOR THE CICATRIZATION OF A WOUND THAT CONTAINS A PIRUVATE, AN ANTIOXIDANT, A MIXED SATURATED FATTY ACIDS AND AN ANTI-VIRAL COMPOUND.
BR9813811A (en) "pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only a single surfactant"
ES2164097T3 (en) USE OF TOPIC ANESTHETICS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF BRONCHIAL ASTHMA.
BRPI0112962B8 (en) pharmaceutical compositions comprising hyaluronic acid, glycyrrhetinic acid and polyvinylpyrrolidone, and use of these compounds in the preparation of medicines
PT1035844E (en) USE OF POLYESES IN THE FIGHTING OF POLYOL LURES AND PREPARATIONS FOR THE REFERENCE USED
ES2061772T3 (en) INHALING AEROSOL INCLUDING A RETINOL ESTER AND / OR RETHINIC ACID.
AR023715A1 (en) PHARMACEUTICAL COMPOSITION FOR A SUBJECT WHO NEEDS AN ELEVATION OF THE CONTENT OF NAD INTRACELLULAR, AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE TO INCREASE THE PROTECTIVE CELLULAR RESPONSES TO GENOTOXIC STRESS IN THE SKIN
UA41989C2 (en) Pharmaceutical composition in form of gel for treating skin diseases and method for treating infected skin
ES2147294T3 (en) THERAPEUTIC COMPOUNDS.
IT1281188B1 (en) COMPOSITION TO PREVENT AND TREAT INFLAMMATION WITH IMMUNOGLOBULIN A.
MX9200894A (en) THERAPEUTIC COMPOSITIONS TO PROTECT AND RESURRECT MAMMALIAN CELLS AND METHODS TO PREPARE AND USE THEM.
SE9200199D0 (en) PHARMACEUTICAL COMPOSITION AND ITS USE
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
JPS6431707A (en) Dermal agent for external use
KR900007424A (en) Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
BR9810711A (en) Topical formulation of antipruritic spray, and, process for prevention or treatment of itching in a patient
DE69133077D1 (en) Preparation of pharmaceutical compositions containing ST1435 for topical use
PT651654E (en) USE OF ONE DENTAL OF LISOZIMASE FOR THE PREPARATION OF A MEDICINAL PRODUCT TO MODIFY NATURAL DEFENSE MECHANISMS
BR9706938A (en) Compound use of the same pharmaceutical formulation and processes to produce the compound and for the treatment or prevention of symptoms or effects of a viral infection in an infected mammal including a human
IT1241079B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
ES2090167T3 (en) TOPIC USE OF GLYCOSAMINOGLYCANS IN THE PREVENTION AND TREATMENT OF DISEASES AFFECTING THE CERVICAL VAGINAL TRACT.
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
US4849221A (en) Pharmaceutical product, containing a mixture of benzoic acid, phenol and an alkali fluoride, for the topical treatment of herpes virus efflorescences, and method for treatment of herpes simplex efflorescences in the human